The laboratory animal diets market in Europe is expected to grow from US$ 1,390.14 million in 2022 to US$ 1,882.51 million by 2028; it is estimated to grow at a CAGR of 5.3% from 2022 to 2028.

Growing Consumption of Personalized Medicines Fuel Europe Laboratory Animal Diets Market

The application of personalized medicine depends heavily on the availability of rigorous diagnostic tools that allow the optimal selection of therapeutic products to improve patient outcomes. According to the Food and Drug Administration (FDA), personalized medicine aims to provide benefits that reduce patient risks by targeting prevention and treatment more effectively. The field of personalized medicine predicts the human response to medicines and diseases based on intraspecific differences. Researchers help in developing approaches to personalized medicines for many genetic disorders. These personalized medicines use custom genetic interventions such as antisense-mediated exon skipping or genome editing to restore protein function in a mutation-specific manner. In drug discovery and development, mice models have played an essential role by characterizing disease pathophysiology and associated injury mechanisms; identifying drug targets; and evaluating novel therapeutics for toxicity/safety, pharmacokinetics, pharmacodynamics, and efficacy. Animal models can facilitate the development of personalized medicine approaches. Personalized medicine approaches need to be developed and preclinically tested in relevant cell and mouse models that ideally contain the human target sequences. The animal models used for personalized medicine research and drug discovery & development are provided with specific diets so that the animal model will react according to the human environment. Therefore, with the rising demand for personalized medicines, the laboratory animal diet market is growing substantially across Europe.

Market Overview

The Europe laboratory animal diets market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The market growth is attributed to the growing demand for animal models to study nutrition-related problems. Additionally, the rising production of animal models by pharmaceutical companies to study treatment for rare diseases such as osteoarthritis and cardiomyopathy is likely to create opportunities for the market players in the coming years. In Germany, pigs are the most used animal models for the clinical validation of drugs and medical devices. Their similarity to humans in terms of physiology, genetics, and anatomy is driving the demand for pig models. For instance, in 2020, the German Centre for Diabetes Research used pig models to examine organ crosstalk and complications in diabetes mellitus. In addition, a rise in the application of pigs as animal models in research activity is contributing to the market growth. Thus, the increasing use of animals for experimental purposes is contributing to the growth of the laboratory animal diet market.

Europe Laboratory Animal Diets Market Revenue and Forecast to 2028 (US$ Million)

Europe Laboratory Animal Diets Market Segmentation

The Europe laboratory animal diets market is segmented into diet type, animal, application, end user, and country.

Based on diet type, the market is segmented into standard diets, irradiated diets, and autoclavable diets. The standard diets segment registered the largest market share in 2022.
Based on animal, the Europe laboratory animal diets market is segmented into mouse, cat, dog, rabbit, chicken, and others. The mouse segment registered the largest market share in 2022.
Based on application, the Europe laboratory animal diets market is segmented into drug discovery and personalized medicines, regenerative medicines, pathology of infectious disease, drug toxicity and efficacy testing, and others. The drug discovery and personalized medicine segment registered the largest market share in 2022.
Based on end user, the Europe laboratory animal diets market is segmented into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others. The pharmaceutical & biopharmaceutical companies segment registered the largest market share in 2022.
Based on country, the Europe laboratory animal diets market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.
Altromin Spezialfutter GmbH & Co. KG, Bio-Serv, Envigo, Krishna Valley Agrotech LLP, LabDiet, Research Diets Inc., SAFE, Special Diet Services, and Specialty Feeds are the leading companies operating in the laboratory animal diets market in Europe.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Laboratory Animal Diet Market – By Diet Type
1.3.2 Europe Laboratory Animal Diet Market – By Animal
1.3.3 Europe Laboratory Animal Diet Market – By Application
1.3.4 Europe Laboratory Animal Diet Market – By End User
1.3.5 Europe Laboratory Animal Diet Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Laboratory Animal Diet Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Laboratory Animal Diet Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Consumption of Personalized Medicines
5.1.2 Rising Usage of Mice Models in Virology and Infectious Disease
5.2 Market Restraints
5.2.1 High Cost of Laboratory Animal Diet due to Maintenance and Wastage
5.3 Market Opportunities
5.3.1 Rising Demand for Humanized Mice Models
5.4 Future Trends
5.4.1 Growing Inclination Toward Customized Diet Plan for Laboratory Animals
5.5 Impact Analysis
6. Laboratory Animal Diet Market – Europe Analysis
6.1 Europe Laboratory Animal Diet Market Revenue Forecast & Analysis
7. Europe Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By Diet Type
7.1 Overview
7.2 Europe Laboratory Animal Diet Market, By Diet Type 2021 & 2028 (%)
7.3 Standard Diet
7.3.1 Overview
7.3.2 Standard Diet Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Irradiated Diet
7.4.1 Overview
7.4.2 Irradiated Diet Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Autoclavable Diet
7.5.1 Overview
7.5.2 Autoclavable Diet Market Revenue and Forecast to 2028 (US$ Mn)
8. Europe Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By Animal
8.1 Overview
8.2 Europe Laboratory Animal Diet Market, By Animal 2021 & 2028 (%)
8.3 Mouse
8.3.1 Overview
8.3.2 Mouse Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Cat
8.4.1 Overview
8.4.2 Cat Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Dog
8.5.1 Overview
8.5.2 Dog Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Rabbit
8.6.1 Overview
8.6.2 Rabbit Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Chicken
8.7.1 Overview
8.7.2 Chicken Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By Application
9.1 Overview
9.2 Europe Laboratory Animal Diet Market, By Application 2021 & 2028 (%)
9.3 Drug Discovery and Personalized Medicine
9.3.1 Overview
9.3.2 Drug Discovery and Personalized Medicine Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Regenerative Medicines
9.4.1 Overview
9.4.2 Regenerative Medicines Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Pathology of Infectious Diseases
9.5.1 Overview
9.5.2 Pathology of Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)
9.6 Drug Toxicity and Efficacy Testing
9.6.1 Overview
9.6.2 Drug Toxicity and Efficacy Testing Market Revenue and Forecast to 2028 (US$ Mn)
9.7 Others
9.7.1 Overview
9.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
10. Europe Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By End User
10.1 Overview
10.2 Europe Laboratory Animal Diet Market, By End User 2021 & 2028 (%)
10.3 Pharmaceutical & Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Pharmaceutical & Biopharmaceutical Companies Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Research & Academic Institutes
10.4.1 Overview
10.4.2 Research & Academic Institutes Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Others
10.5.1 Overview
10.5.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
11. Europe Laboratory Animal Diet Market Revenue and Forecasts to 2028 – Country Analysis
11.1 Overview
11.1.1 Europe: Laboratory Animal Diet Market, by Country, 2021 & 2028 (%)
11.1.1.1 Germany: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Germany: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Germany: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 Germany: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 Germany: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.6 Germany: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 UK: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 UK: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 UK: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 UK: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 UK: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.6 UK: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 France: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 France: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 France: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 France: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 France: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.6 France: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4 Italy: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Italy: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Italy: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.4 Italy: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.5 Italy: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.6 Italy: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5 Spain: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 Spain: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.3 Spain: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.4 Spain: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.5 Spain: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.6 Spain: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6 Rest of Europe: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3 Rest of Europe: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.4 Rest of Europe: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.5 Rest of Europe: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.6 Rest of Europe: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
12. Europe Laboratory Animal Diet Market– Industry Landscape
12.1 Overview
13. Company Profiles
13.1 Envigo
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Altromin Spezialfutter GmbH & Co. KG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 LabDiet
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 SAFE
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Special Diet Services
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Specialty Feeds
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Research Diets Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bio-Serv
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Krishna Valley Agrotech LLP
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. UK: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 13. France: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. Italy: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Italy: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
Table 16. Italy: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 18. Spain: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 21. Spain: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Europe: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Europe: Laboratory Animal Diet Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Merger and Acquisition Development Done By Company
Table 27. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Laboratory Animal Diet Market Segmentation
Figure 2. Europe Laboratory Animal Diet Market, By Country
Figure 3. Europe Laboratory Animal Diet Market Overview
Figure 4. Europe Laboratory Animal Diet Market, By Diet Type
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Europe Laboratory Animal Diet Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Europe Laboratory Animal Diet Market, by Diet Type 2021 & 2028 (%)
Figure 10. Europe Standard Diet Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Europe Irradiated Diet Market Revenue and Forecasts To 2028 (US$ MN)
Figure 12. Europe Autoclavable Diet Market Revenue and Forecasts To 2028 (US$ MN)
Figure 13. Europe Laboratory Animal Diet Market, by Animal 2021 & 2028 (%)
Figure 14. Europe Mouse Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Europe Cat Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Europe Dog Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe Rabbit Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Europe Chicken Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Europe Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Europe Laboratory Animal Diet Market, by Application 2021 & 2028 (%)
Figure 21. Europe Drug Discovery and Personalized Medicine Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Europe Regenerative Medicines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Europe Pathology of Infectious Diseases Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Europe Drug Toxicity and Efficacy Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Europe Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Europe Laboratory Animal Diet Market, by End User 2021 & 2028 (%)
Figure 27. Europe Pharmaceutical & Biopharmaceutical Companies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Europe Research & Academic Institutes Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Europe Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Europe: Laboratory Animal Diet Market, by Key Country – Revenue (2021) (US$ Million)
Figure 31. Europe: Laboratory Animal Diet Market, by Country, 2021 & 2028 (%)
Figure 32. Germany: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. UK: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. France: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Italy: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Spain: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Rest of Europe: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe laboratory animal diet market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Europe laboratory animal diet market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the laboratory animal diet market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

● Altromin Spezialfutter GmbH & Co. KG
● Bio-Serv
● Envigo
● Krishna Valley Agrotech LLP
● LabDiet
● Research Diets Inc.
● SAFE
● Special Diet Services
● Specialty Feeds

At 5.3% CAGR, the Europe Laboratory Animal Diet Market is speculated to be worth US$ 1,882.51 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Europe laboratory animal diet market was valued at US$ 1,390.14 million in 2022 and is expected to reach US$ 1,882.51 million by 2028, registering a CAGR of 5.3% from 2022 to 2028. Rising usage of mice models in virology and infectious diseases and growing consumption of personalized medicines are the critical factors attributed to the market expansion.

Mice models are essential tools for studying the pathogenesis of infectious diseases and for the preclinical evaluation of vaccines and therapies against various human pathogens. The use of genetically defined inbred mouse strains, humanized mice, and gene knockout mice has enabled the research community to study how pathogens cause diseases and explain the role of specific host genes in controlling or promoting diseases. It also helps determine potential targets for prevention or identification of treatments for various infectious agents. With the emergence of new infectious diseases, the animal model has become a vital tool for studying disease mechanisms and developing therapeutics. Mice with xenografted human immune systems have been used to study the pathogenesis of various infectious agents, including Plasmodium falciparum (malaria), Mycobacterium tuberculosis, dengue virus, and influenza virus. These models have been beneficial in studying HIV, which includes analyzing viral and host factors that promote viral replication and HIV interactions with the host’s immune response. They are also helpful as platforms for testing therapeutic approaches to control HIV infection. Mouse models are widely used for preclinical screening of vaccines/therapies because of their reproducibility, low cost, and ease of experimental manipulation. Over the past century, advancements in vaccines, antibiotics/antivirals, and infection control measures have significantly reduced the burden of infectious diseases on public health. However, there has been an increase in contagious viral diseases. Mouse models are considered the best small animal models to be tested for hepatitis B virus (HBV), hepatitis C virus (HCV), Zika virus, SARS-CoV-2, and cytomegalovirus (CMV). According to the WHO, more than 17 million people die from infectious diseases yearly. Over the past two decades, over 30 new infectious diseases have emerged. According to UNAIDS, 38 million people were affected by HIV by the end of 2019. Mouse models have been widely used for various viral studies due to their small size, low cost, ease of use, and high reproducibility. To study the effect of the vaccines and therapies, these mice models are given a particular standardized diet according to the need of the mice model. The prevalence of viral and infectious disease is driving the growth of the overall mice models due to which there is requirement of specific diet for the mice models. This is driving the growth of the Laboratory Animal Diet market.

On the contrary, high cost of laboratory animal diets due to maintenance and wastage hurdles the growth of Europe laboratory animal diet market.

Based on diet type, the Europe laboratory animal diet market is segmented into standard diets, irradiated diets, and autoclavable diets. The standard diets segment held 62.7% market share in 2022, amassing US$ 871.36 million. It is projected to garner US$ 1,176.63 million by 2028 to expand at 5.1% CAGR during 2022–2028.

Based on animal, the Europe laboratory animal diet market is segmented into mouse, cat, dog, rabbit, chicken, and others. The mouse segment held 45.3% market share in 2022, amassing US$ 629.55 million. It is projected to garner US$ 870.40 million by 2028 to expand at 5.5% CAGR during 2022–2028.

Based on application, the Europe laboratory animal diet market is segmented into drug discovery and personalized medicines, regenerative medicines, pathology of infectious disease, drug toxicity and efficacy testing, and others. The drug discovery and personalized medicine segment held 48.0%market share in 2022, amassing US$ 667.81 million. It is projected to garner US$ 884.21 million by 2028 to expand at 4.8% CAGR during 2022–2028.

Based on end user, the Europe end user market is segmented into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others. The pharmaceutical & biopharmaceutical companies segment held 58.7% market share in 2022, amassing US$ 815.81 million. It is projected to garner US$ 1,092.46 million by 2028 to expand at 5.0% CAGR during 2022–2028.

Based on country, the Europe laboratory animal diet market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.5% market share in 2022. It was assessed at US$ 409.40 million in 2022 and is likely to hit US$ 541.98 million by 2028, exhibiting a CAGR of 4.8% during the forecast period.

Key players dominating the Europe laboratory animal diet market are Altromin Spezialfutter GmbH & Co. KG, Bio-Serv, Envigo, Krishna Valley Agrotech LLP, LabDiet, Research Diets Inc., SAFE, Special Diet Services, and Specialty Feeds among others.